“…Today, a simple equivalence test first introduced by Schuirmann et al [37] is accepted, for example, as standard for bioequivalence assessment [38], namely, the two one-sided t-test (TOST). In contrast to the two-sample t-test, the null hypothesis of the TOST states that the two means are not equivalent [36]. The impact of the null hypothesis is that in the case of small sample sizes and/or poor precision (large variance) in one or both groups, equivalence is rejected, resulting in low numbers of false-positive test results [39].…”